That’s the world we envision. And it’s why we continue to push the boundaries of what’s possible. Collaborating in new and exciting ways to develop innovative solutions that advance patient care and expand access.
Now — with the addition of data & analytics and robotics — our portfolio of surgical technologies isn’t just practical. It’s visionary.
With the Hugo™ RAS system, minimally invasive robotic surgery can be within reach for more people, in more places than ever before.
Not approved by the FDA for any use and not commercially available in the US.
So we can shape the future of surgery, together.
The Medtronic Hugo™ RAS system is not cleared or approved in all markets. In the US, the Hugo™ system is an investigational device not for sale. Regulatory requirements of individual countries and regions will determine availability and approval or clearance timelines.
Touch Surgery™ Enterprise is not intended to direct surgery, or aid in diagnosis or treatment of a disease or condition.